Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,832,056
+$40,299 QoQ
Shares Held
11,690
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#453
of 1,603 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glass Wealth Management Co LLC holds $16,275,469 across 9 Drug Manufacturers - General names. NVS ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,448 | $5,335,065 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,119 | $3,741,791 | |
| 3 | PFE |
Pfizer Inc
|
100,166 | $2,411,997 | |
| 4 | SNY |
Sanofi
|
43,650 | $1,862,109 | |
| 5 | NVS |
Novartis AG
This page
|
11,690 | $1,832,056 | |
| 6 | ABBV |
AbbVie Inc.
|
1,618 | $407,153 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,845 | $233,097 | |
| 8 | AMGN |
Amgen Inc
|
640 | $231,756 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,832,056 | 11,690 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,791,757 | 11,730 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,611,010 | 11,685 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,617,747 | 12,615 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,489,633 | 12,310 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,372,318 | 12,310 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,212,482 | 12,460 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,433,149 | 12,460 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,326,491 | 12,460 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,211,543 | 12,525 | Shares | Sole | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||